A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

Completed

Conditions studied: Attention Deficit Disorder With Hyperactivity

In brief

This noninterventional study will assess genomic changes in the metabotropic glutamate receptor (mGluR) network in children and adolescents with ADHD.

Key facts

Study ID

NCT02811211

Run by

Aevi Genomic Medicine, LLC, a Cerecor company

People needed

1894

Starts

2016-02-01

Expected to finish

2017-01-06

Last updated by the study team

2021-07-06

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject is male or female ≥6 and ≤17 years of age.
• The subject has ADHD as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition.
• The subject, his or her legally responsible representative, and investigator agree to complete ADHD history, treatment, and comorbidity electronic case report form (eCRF).

You may not qualify if…

• The subject or parent/legal guardian is in the opinion of the investigator mentally or legally incapacitated and unable to provide informed consent/assent for participation in the study.

Where it is running

• A.I. DuPont Hospital for Children — Wilmington, Delaware, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.